Prior Presentation: This work was presented in part as a poster at the Endocrine Society (ENDO) Annual Meeting held July 1215, 2025, in San Francisco, CA, USA
doi: 10.1042/bj0240199 PubMed Abstract | CrossRef Full Text | Google Scholar Stanhill, G
PubMed Randomized trialTirzepatide evidence2025 Tirzepatide for Obesity Treatment and Diabetes Prevention Supports newer discussion of obesity treatment and diabetes-prevention outcomes
When mitochondria fail, neurons die
The cash-pay telehealth market for GLP-1 medications has matured rapidly, and in 2026 there are now several reputable programs offering monthly pricing that's accessible without going through traditional insurance channels
A go to add on for fatigue and low energy days